Remove 2019 Remove Chronic Condition Remove IT Remove Provider
article thumbnail

Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino

GeriPal

In our prior podcast with Ira Byock on psychedelics in 2019 we talked primarily about the potential of psychedelics. Eric, did you take your ketamine before this podcast? Eric: No, I did a little psilocybin. Eric: Thanks to our Ira Byock podcast. I forget how long ago that was. We’re going to talk about that. Alex: Yeah, yeah, it does.

article thumbnail

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law Blog

A May 2019 CMS final rule that would have required drug TV advertisements to disclose the WAC of the drug was challenged by a group of pharmaceutical companies and vacated on statutory grounds by the D.C. Last Thursday, the U.S. The actual policy proposals read like a wish list. Below, we summarize the key proposals of the HHS plan.